How do we manage patients with refractory or breakthrough emesis?

Supportive Care in Cancer

Volumn 10, Issue 2, 2002, Pages 106-109

  Aapro, Matti S ^a  

^a CLINIQUE DE GENOLIER   (Switzerland)

Author keywords

Breakthrough; Emesis; Nausea; Refractory; Vomiting

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CISPLATIN; CORTICOSTEROID; DEXAMETHASONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DROPERIDOL; GRANISETRON; HALOPERIDOL; LEVOMEPROMAZINE; METOCLOPRAMIDE; METOPIMAZINE; NEUROLEPTIC AGENT; ONDANSETRON; PROPOFOL; SEDATIVE AGENT; SEROTONIN 3 ANTAGONIST; STEROID; SUMATRIPTAN; TRANQUILIZER;

ANTIEMETIC ACTIVITY; CANCER PATIENT; DISEASE CONTROL; DOSE RESPONSE; DRUG EFFECT; DRUG USE; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VOMITING;

ANTINEOPLASTIC AGENTS; HUMANS; PRACTICE GUIDELINES; TREATMENT OUTCOME; UNITED STATES; VOMITING;

EID: 0036943056     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200100288     Document Type: Review

References (19)

1. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) (1998) Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Ann Oncol 9:811-819
2. Koeller JM, Aapro MS, Gralla RJ, et al (2001) Antiemetic guidelines: creating a more practical treatment approach. Ann Oncol (submitted)
3. Roila F, De Angelis V, Patoia L, Pignata S, Sorio R, Labianca R, Iacono C, Lelli G, Tonato M (2000) Antiemetic prescriptions in 77 Italian Oncological Centers after the MASCC Consensus Conference. Support Care Cancer 8:241
4. Perez EA, Hesketh P, Sandbach J, et al (1998) Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. J Clin Oncol 16:754-760
5. Gralla RJ, Navari RM, Hesketh PJ, et al (1998) Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy. J Clin Oncol 16:1568-1673
6. Herrstedt J (1998) Antiemetic research: a look to the future. Support Care Cancer 6:8-12
7. De Mulder PH, Roila F, Kris MG, Marty MM (1998) Consensus regarding multiple day and rescue antiemetic therapy. Support Care Cancer 6:248-252
8. Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971-2994
9. Horgan KJ, Eldridge KN, Carides A, et al (2001) Differential time course of cisplatin induced acute emesis with a 5-HT3 antagonist or an NK1 antagonist: rationale for combination therapy. Proc Am Soc Clin Oncol 24:1528
10. Cupissol DR, Serrou B, Caubel M (1990) The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis. Eur Cancer 26 [Suppl 1]: S23-S27
11. Aapro MS, Froidevaux P, Roth A, Alberto P (1991) Antiemetic efficacy of droperidol or metoclopramide combined with dexamethasone and diphenhydramine. Randomized parallel study. Oncology 42:116-120
12. Borgeat A, Wilder-Smith O, Forni M, Suter PM (1994) Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer. Can J Anaesth 41:1117-1119
13. Dominguez-Ortega L, Cubedo-Cervera R, Cortes-Funes H, Diaz-Gallego E (1996) Sleep protects against chemotherapy-induced emesis. Cancer 77: 1566-1570
14. Ladabaum U, Hasler WL (1999) Novel approaches to the treatment of nausea and vomiting. Dig Dis 17:125-132
15. Nelson-Piercy C, Fayers P, de Swiet M (2001) Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. Br J Obstet Gynaecol 108:9-15
16. Safari HR, Fassett MJ, Souter IC, Alsulyman OM, Goodwin TM (1998) The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol 178:1054-1058
17. Carmichael J, Keizer HJ, Cupissol D, Milliez J, Scheidel P, Schindler AE (1998) Use of granisetron in patients refractory to previous treatment with antiemetics. Anticancer Drugs 9:381-385
18. de Wit R, Boer A, Linden G van de (2001) Randomized double blind study of granisetron (G) vs continued treatment with ondansetron (O) in patients failing on O plus dexamethasone (D) during the first 24 hours following highly emetogenic chemotherapy. Proc Am Soc Clin Oncol 24:1597
19. Sigsgaard T, Herrstedt J, Christensen P, Andersen O, Dombernowsky P (2000) Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy. Support Care Cancer 8:233-237